Concord Medical Co., Ltd. (6518.TWO)
TWD 25.8
(0.0%)
TWD 25.8
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 113.22 Million | 154.56 Million | 137.42 Million | 84.06 Million | 131.05 Million |
| Net Income | 54.52 Million | 64.22 Million | 42.78 Million | 25.57 Million | 31.37 Million |
| Depreciation & Amortization | 79.43 Million | 76.42 Million | 96.59 Million | 103.19 Million | 105.09 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -3.38 Million | 25.95 Million | 13.8 Million | -34.12 Million | -17.01 Million |
| Other non-cash items | 646 Thousand | 2.52 Million | 3.59 Million | 5.29 Million | 11.59 Million |
| Investing Cash Flow | -188.08 Million | -110.31 Million | 33.17 Million | -54.85 Million | -31.05 Million |
| Investments in PPE | -89.68 Million | -38.07 Million | -21.94 Million | -93.98 Million | -69.93 Million |
| Acquisitions | -35.51 Million | - | - | - | - |
| Investment purchases | -109 Million | -97.23 Million | - | - | -6.76 Million |
| Sales/Maturities of investments | - | - | 80 Thousand | 3.34 Million | 7.03 Million |
| Other Investing Activities | 6.13 Million | 5.15 Million | -178 Thousand | 381 Thousand | 38.88 Million |
| Financing Cash Flow | -60.79 Million | 3.86 Million | -31.22 Million | -46.51 Million | -60.14 Million |
| Debt repayment | -35 Million | -19.57 Million | -100.93 Million | -15.39 Million | -41.41 Million |
| Dividends payments | -33.33 Million | -16.66 Million | -10 Million | -10 Million | -10 Million |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | 100 Million | - | - |
| Other Financing Activities | -40.35 Million | 40.1 Million | -530 Thousand | -60 Thousand | -8.72 Million |
| Accounts receivables | 9.47 Million | -2.71 Million | 6.63 Million | -19.2 Million | -18.99 Million |
| Accounts payables | -15.14 Million | - | - | - | - |
| Inventory | 2.01 Million | 3.17 Million | -6.52 Million | 789 Thousand | 390 Thousand |
| Other working capital | 257 Thousand | 7.66 Million | 13.02 Million | -30.65 Million | 1.59 Million |
| Cash at beginning of period | 246.91 Million | 198.79 Million | 59.42 Million | 76.72 Million | 36.86 Million |
| Cash at end of period | 111.26 Million | 246.91 Million | 198.79 Million | 59.42 Million | 76.72 Million |
| Capital Expenditure | -89.68 Million | -38.07 Million | -21.94 Million | -93.98 Million | -69.93 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -135.65 Million | 48.11 Million | 139.37 Million | -17.3 Million | 39.86 Million |
| Free Cash Flow | 23.54 Million | 116.48 Million | 115.47 Million | -9.91 Million | 61.12 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 11.89 Million | 11.89 Million | 11.6 Million | 54.52 Million | 11.6 Million | 9.76 Million |
| Depreciation & Amortization | 21.21 Million | 20.8 Million | 19.83 Million | 79.43 Million | 19.83 Million | 19.47 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -10.79 Million | -10.79 Million | -6.48 Million | -3.38 Million | -6.48 Million | 12.36 Million |
| Other non-cash items | 138 Thousand | 541.5 Thousand | 6.85 Million | 646 Thousand | 6.85 Million | -16.79 Million |
| Investing Cash Flow | -12.2 Million | -12.2 Million | -78.62 Million | -188.08 Million | -78.62 Million | -15.41 Million |
| Investments in PPE | -10.99 Million | -10.99 Million | -13.31 Million | -89.68 Million | -13.31 Million | -30.77 Million |
| Acquisitions | 259 Thousand | - | - | - | - | - |
| Investment purchases | - | - | - | -109 Million | - | - |
| Sales/Maturities of investments | 3.5 Million | - | - | - | - | - |
| Other Investing Activities | -1.21 Million | -1.21 Million | -65.3 Million | 6.13 Million | -65.3 Million | 15.35 Million |
| Financing Cash Flow | -22.77 Million | -22.77 Million | 11.82 Million | -60.79 Million | 11.82 Million | -42.22 Million |
| Debt repayment | - | - | - | -35 Million | - | - |
| Dividends payments | -33.33 Million | -16.66 Million | - | -33.33 Million | - | -16.66 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -6.11 Million | -6.11 Million | 11.82 Million | -40.35 Million | 11.82 Million | -25.55 Million |
| Accounts receivables | -9.44 Million | -9.44 Million | -10.95 Million | 9.47 Million | -10.95 Million | 15.69 Million |
| Accounts payables | -2.24 Million | - | - | - | - | - |
| Inventory | -367.5 Thousand | -367.5 Thousand | 3.65 Million | 2.01 Million | 3.65 Million | -2.64 Million |
| Other working capital | -979.5 Thousand | -979.5 Thousand | 810 Thousand | 257 Thousand | 810 Thousand | -681.5 Thousand |
| Cash at beginning of period | 111.26 Million | - | - | 246.91 Million | 181.23 Million | 214.07 Million |
| Cash at end of period | -12.54 Million | -12.54 Million | -34.98 Million | 111.26 Million | 146.24 Million | 181.23 Million |
| Capital Expenditure | -10.99 Million | -10.99 Million | -13.31 Million | -89.68 Million | -13.31 Million | -30.77 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -123.8 Million | -12.54 Million | -34.98 Million | -135.65 Million | -34.98 Million | -32.83 Million |
| Free Cash Flow | 11.45 Million | 11.45 Million | 18.49 Million | 23.54 Million | 18.49 Million | -5.97 Million |
CLF
GZDIF
MCBI
CEMEXCPO
MFL
FCSSOFT